Business
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, announced that it will present at the following conferences during May: Bank of America Global Healthcare Conference 2025 in Las VegasPresentation: Thursday, May 15 at 12:35 p.m. ET H.C. Wainwright 3rd Annual BioConnect
About this update from Aardvark Therapeutics, Inc.
[{"type":"image","alt":"Aardvark Therapeutics, Inc.","displaySize":"","headline":null,"caption":"Aardvark Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":63,"url":"https://media.zenfs.com/en/globenewswire.com/fe55bd926bdb60296161677c87a21101"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_2n1g9xWdfu1GQlbvtkO7g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg4O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/fe55bd926bdb60296161677c87a21101","width":300,"height":63}},"lazy":false},{"type":"text","content":"SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, announced that it will present at the following conferences during May:","length":351,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Bank of America Global Healthcare Conference 2025 in Las VegasPresentation: Thursday, May 15 at 12:35 p.m. ET","length":110,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":110,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"H.C. Wainwright 3rd Annual BioConnect Investor Conference in New YorkPresentation: Tuesday, May 20 at 3:30 p.m. ET","length":115,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":115,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"2025 RBC Capital Markets Global Healthcare Conference in New YorkPresentation: Wednesday, May 21 at 2:35 p.m. ET","length":113,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":113,"olType":false},{"type":"text","content":"Live webcasts of each presentation will be accessible on the company’s website, www.aardvarktherapeutics.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation.","length":253,"tagName":"p"},{"type":"text","content":"About Aardvark Therapeutics, Inc.Aardvark is a clinical-stage biopharmaceutical company developing novel, small-molecule therapeutics designed to suppress hunger for the treatment of PWS and metabolic diseases. Recognizing hunger (the discomfort from not having eaten recently) is a distinct neural signal...